arrow
D

Daisaku Yamada

The University of Osaka
H指数:33
被引数:3,580

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Self-assembling peptide hydrogel SPG-178 effectively prevents postoperative pancreatic fistula compared with polyglycolic acid mesh with fibrin glue in rats

与聚乙醇酸网片联合纤维蛋白胶相比,自组装肽水凝胶SPG-178可有效预防大鼠术后胰瘘

2026-10-150
OAAI
Relationship Between Radiographic and Pathological Portal Vein-Superior Mesenteric Vein Involvement in Neoadjuvant Treatment for Pancreatic Cancer: A Comparative Study of Neoadjuvant Chemotherapy and Chemoradiotherapy

胰腺癌新辅助治疗中影像学及病理学门静脉-肠系膜上静脉受侵的关系:新辅助化疗与化放疗的对比研究

2026-06-010
OAAI
Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma

肿瘤相关高内皮静脉与切除的肝细胞癌中淋巴细胞浸润增强及良好预后相关

2025-12-190
OAAI
Assessment of Surgical Invasiveness in Hepatobiliary and Pancreatic Surgeries by Quantifying Intraoperative Energy Expenditure: A Comparison Between Laparoscopic and Open Surgery

通过量化术中能量消耗评估肝胆胰手术的手术侵袭性:腹腔镜手术与开腹手术的比较

2025-12-040
PRE
IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts

肝切除术期间释放的IL-33通过癌症相关成纤维细胞中的细胞因子分泌促进肝内胆管癌生长。

2025-11-230
PRE
Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma

事后亚组分析:新辅助吉西他滨联合S1方案与吉西他滨联合nab-紫杉醇方案在老年可切除/临界可切除胰腺腺癌中的比较

2025-11-120
OAAI
Graft trimming with LigaSure™ and leak testing with Indigo carmine reduces blood loss significantly after reperfusion in pancreas transplantation

使用LigaSure™进行移植物修剪并用靛蓝胭脂红进行渗漏测试,可显著减少胰腺移植再灌注后的失血量。

2025-11-010
PRE
Response to the letter to the Editor: “Refining the Prognostic Utility of CA19-9 in Neoadjuvant Therapy for Pancreatic Cancer: Emphasizing Serial Monitoring and Subgroup Differentiation”

对致编辑信的回应:“优化CA19-9在胰腺癌新辅助治疗中的预后价值:强调系列监测和亚组区分”

2025-09-300
PRE
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular Carcinoma

肿瘤内皮细胞通过IL-4诱导M2型巨噬细胞极化,增强肝细胞癌的生长

2025-08-270
OAAI
Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy

胰腺癌新辅助治疗中放射学与病理学反应评估的差异:新辅助化疗与新辅助化放疗的比较

2025-06-280
OAAI
Dynamic contrast-enhanced CT-derived extracellular volume fraction for predicting postoperative oncologic outcomes in pancreatic ductal adenocarcinoma

动态增强CT衍生细胞外容积分数在预测胰腺导管腺癌术后肿瘤学结局中的应用

2025-06-180
OA
Preoperative nutritional status is a useful predictor of the feasibility of postoperative treatment in octogenarian-plus pancreatic ductal adenocarcinoma patients

术前营养状况是八十岁以上胰腺导管腺癌患者术后治疗可行性的有用预测指标

EJSO
IF2.9
2024-12-011
PRE